MEI Pharma Inc (MEIP)
3.03
-0.11
(-3.50%)
USD |
NASDAQ |
Nov 13, 16:00
3.15
+0.12
(+3.96%)
After-Hours: 20:00
MEI Pharma Cash from Operations (Quarterly): -18.00M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.00M |
| March 31, 2024 | -2.928M |
| December 31, 2023 | -11.06M |
| September 30, 2023 | -18.49M |
| June 30, 2023 | -11.30M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -14.27M |
| September 30, 2022 | -14.78M |
| June 30, 2022 | -15.50M |
| March 31, 2022 | -16.96M |
| December 31, 2021 | -8.566M |
| September 30, 2021 | -7.721M |
| June 30, 2021 | -11.26M |
| March 31, 2021 | -15.65M |
| December 31, 2020 | 4.05M |
| September 30, 2020 | -9.111M |
| June 30, 2020 | 69.11M |
| March 31, 2020 | -10.30M |
| December 31, 2019 | -10.48M |
| September 30, 2019 | -14.08M |
| June 30, 2019 | -8.064M |
| March 31, 2019 | -11.34M |
| December 31, 2018 | 2.799M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -3.483M |
| Date | Value |
|---|---|
| March 31, 2018 | -6.239M |
| December 31, 2017 | -4.751M |
| September 30, 2017 | -6.562M |
| June 30, 2017 | -3.146M |
| March 31, 2017 | 1.606M |
| December 31, 2016 | -3.747M |
| September 30, 2016 | 8.773M |
| June 30, 2016 | -3.483M |
| March 31, 2016 | -4.385M |
| December 31, 2015 | -4.228M |
| September 30, 2015 | -5.761M |
| June 30, 2015 | -6.742M |
| March 31, 2015 | -8.148M |
| December 31, 2014 | -6.448M |
| September 30, 2014 | -6.731M |
| June 30, 2014 | -5.85M |
| March 31, 2014 | -5.071M |
| December 31, 2013 | -4.467M |
| September 30, 2013 | -4.063M |
| June 30, 2013 | -2.766M |
| March 31, 2013 | -2.631M |
| December 31, 2012 | -2.16M |
| September 30, 2012 | -2.487M |
| June 30, 2012 | -1.304M |
| March 31, 2012 | -2.273M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.49M
Minimum
Sep 2023
69.11M
Maximum
Jun 2020
-7.123M
Average
-11.26M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Avid Bioservices Inc | -3.68M |
| Evoke Pharma Inc | -0.8206M |
| Revance Therapeutics Inc | -41.09M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 19.54M |
| Cash from Financing (Quarterly) | -0.208M |
| Free Cash Flow | -50.48M |
| Free Cash Flow Per Share (Quarterly) | -2.701 |
| Free Cash Flow Yield | -250.0% |